Recently published Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic kidney disease emerging drugs, market share of ...

Emcure Pharmaceuticals today announced the signing of a distribution agreement with Roche for select products in the ...

At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...

Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.

Kidney beans contain slightly more fiber and protein than black beans, but the difference is small.Iron content is essentially the same in black beans and kidney beans.Both beans are healthy choices ...

Iron deficiency anemia affects millions. Learn about its causes, symptoms, and the importance of addressing this common condition promptly.

Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 ...

A depression diagnosis may contribute to kidney disease progression for adults with chronic kidney disease, according to study data published in Frontiers in Nephrology. Depression has been linked to ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics announced the official establishment of its rare kidney disease pipeline. This ...

ABSTRACT: Introduction: Anaemia is one of the most common complications of Chronic Kidney Disease (CKD) and significantly impairs the quality of life of patients undergoing chronic haemodialysis. The ...

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD ...